11,641 reports of this reaction
23.0% of all TAPENTADOL HYDROCHLORIDE reports
#1 most reported adverse reaction
DEATH is the #1 most commonly reported adverse reaction for TAPENTADOL HYDROCHLORIDE, manufactured by Collegium Pharmaceutical, Inc.. There are 11,641 FDA adverse event reports linking TAPENTADOL HYDROCHLORIDE to DEATH. This represents approximately 23.0% of all 50,606 adverse event reports for this drug.
TAPENTADOL HYDROCHLORIDE has an overall safety score of 92 out of 100. Patients taking TAPENTADOL HYDROCHLORIDE who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is a frequently reported adverse event for TAPENTADOL HYDROCHLORIDE, accounting for a significant proportion of all reports.
In addition to death, the following adverse reactions have been reported for TAPENTADOL HYDROCHLORIDE:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 11,641 FDA reports for TAPENTADOL HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 23.0% of all adverse event reports for TAPENTADOL HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience death while taking TAPENTADOL HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.